• 1. Identification and quantification of methylated PAHs in sediment by two-dimensional gas chromatography/mass spectrometry
  Ewa Skoczynska,Pim Leonards,Jacob de Boer Anal. Methods 2013 5 213
• 2. Identification of environmental polynuclear aromatic hydrocarbons by pulse Fourier-transform 1H nuclear magnetic resonance spectroscopy
  K. D. Bartle,M. L. Lee,M. Novotny Analyst 1977 102 731
• 3. An alternative to trial and error methodology in solid phase extraction: an original automated solid phase extraction procedure for analysing PAHs and PAH-derivatives in soot
  Auréa Andrade-Eiroa,Roya Shahla,Manolis N. Romanías,Philippe Dagaut RSC Adv. 2014 4 33636

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenanthrenes and derivatives Phenanthrenes and derivatives
• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenanthrenes and derivatives

Introduction to 2-Methylbenzaanthracene (CAS No. 2498-76-2)

2-Methylbenzaanthracene, identified by the Chemical Abstracts Service Number (CAS No.) 2498-76-2, is a polycyclic aromatic hydrocarbon (PAH) derivative that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, characterized by a benzene ring fused with two aromatic rings, serves as a valuable intermediate in synthetic chemistry and a model molecule for studying the mechanisms of carcinogenesis and environmental toxicology.

The structural uniqueness of 2-Methylbenzaanthracene lies in its methyl substitution on the benzene ring, which influences its electronic properties, reactivity, and biological interactions. As a derivative of benzo[a]anthracene, it shares structural similarities with other PAHs but exhibits distinct pharmacokinetic and toxicological profiles. The presence of the methyl group enhances its solubility in organic solvents, making it a versatile candidate for various chemical modifications and derivatization processes.

In recent years, 2-Methylbenzaanthracene has been extensively studied for its potential applications in drug development and cancer research. Its ability to intercalate into DNA and induce mutations has made it a useful tool for investigating the pathways involved in genotoxicity. Researchers have leveraged this compound to develop novel chemotherapeutic agents that target specific DNA sequences, offering promising avenues for treating PAH-induced malignancies.

One of the most compelling aspects of 2-Methylbenzaanthracene is its role as a probe molecule in environmental science. Studies have demonstrated its persistence in aquatic ecosystems and its potential to bioaccumulate in organisms. By examining the degradation pathways of this compound, scientists have gained insights into the broader impacts of PAHs on ecological health. Furthermore, advancements in biodegradation techniques have highlighted the importance of microorganisms in mitigating environmental contamination caused by such compounds.

The pharmaceutical industry has also capitalized on the chemical versatility of 2-Methylbenzaanthracene. Researchers have synthesized numerous derivatives that exhibit enhanced pharmacological properties, including improved bioavailability and reduced toxicity. For instance, modifications to the methyl group or introduction of functionalized side chains have yielded compounds with potent anti-inflammatory and antioxidant effects. These findings underscore the compound's significance as a scaffold for developing next-generation therapeutics.

From a synthetic chemistry perspective, 2-Methylbenzaanthracene serves as a critical building block for constructing more complex molecular architectures. Its fused ring system provides a stable platform for introducing diverse substituents, enabling the creation of libraries of compounds with tailored biological activities. Techniques such as cross-coupling reactions and metal-catalyzed transformations have been employed to modify its structure, leading to novel derivatives with applications ranging from agrochemicals to medicinal chemistry.

The toxicological profile of 2-Methylbenzaanthracene has been thoroughly investigated to understand its mechanisms of action at both cellular and molecular levels. Studies indicate that it induces oxidative stress and DNA damage upon exposure, contributing to its carcinogenic potential. However, recent research has also revealed its role in modulating immune responses, suggesting therapeutic applications in immunotherapy. By elucidating these pathways, scientists aim to develop strategies that mitigate its harmful effects while harnessing its beneficial properties.

Emerging technologies such as high-throughput screening and computational modeling have accelerated the discovery process for 2-Methylbenzaanthracene-based compounds. These tools allow researchers to predict biological activities and optimize molecular structures with unprecedented precision. As a result, there is growing optimism that this compound will continue to inspire innovative approaches in drug discovery and environmental remediation.

In conclusion, 2-Methylbenzaanthracene (CAS No. 2498-76-2) represents a cornerstone in modern chemical biology and pharmaceutical research. Its unique structural features, coupled with its diverse applications across multiple disciplines, make it an indispensable tool for advancing scientific knowledge and developing novel solutions to global challenges. As research progresses, it is anticipated that new insights into its properties will further expand its utility in medicine, ecology, and materials science.

• 779-02-2(9-Methylanthracene)
• 781-43-1(9,10-Dimethylanthracene)
• 582-16-1(2,7-Dimethylnaphthalene)
• 1576-67-6(3,6-Dimethylphenanthrene)
• 1321-94-4(Methylnaphthalene)
• 2381-21-7(1-Methylpyrene)
• 483-87-4(1,7-Dimethyl-phenanthrene)
• 571-61-9(1,5-Dimethylnaphthalene)
• 28804-88-8(Dimethylnaphthalene, mixture of isomers)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)